A. Leonardini

发表

GLP-1: a new approach for type 2 diabetes therapy

F. Giorgino, A. Natalicchio, L. Laviola, 2006 .

Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling.

R. Giorgino, F. Giorgino, S. Perrini, 2005, Endocrinology.

Abnormalities of insulin-like growth factor-I signaling and impaired cell proliferation in osteoblasts from subjects with osteoporosis.

R. Giorgino, M. Melchiorre, F. Giorgino, 2008, Endocrinology.

Long-Term Exposure of Pancreatic β-Cells to Palmitate Results in SREBP-1C-Dependent Decreases in GLP-1 Receptor Signaling via CREB and AKT and Insulin Secretory Response.

F. Giorgino, S. Perrini, A. Cignarelli, 2016, Endocrinology.

Glucagon-like peptide-1 counteracts oxidative stress-dependent apoptosis of human cardiac progenitor cells by inhibiting the activation of the c-Jun N-terminal protein kinase signaling pathway.

M. Melchiorre, F. Giorgino, A. Natalicchio, 2012, Endocrinology.

GLP‐1 Receptor Activation Inhibits Palmitate‐Induced Apoptosis via Ceramide in Human Cardiac Progenitor Cells

F. Giorgino, S. Perrini, A. Cignarelli, 2017, The Journal of clinical endocrinology and metabolism.

The p66Shc protein controls redox signaling and oxidation-dependent DNA damage in human liver cells.

M. De Fazio, F. Puglisi, F. Giorgino, 2015, American journal of physiology. Gastrointestinal and liver physiology.

The p66 protein controls redox signaling and oxidation-dependent DNA damage in human liver cells

F. Puglisi, S. Perrini, A. Cignarelli, 2015 .

The p66Shc redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells

M. Bugliani, P. Marchetti, A. Avogaro, 2015, Diabetologia.

Pathophysiology of type 2 diabetes: rationale for different oral antidiabetic treatment strategies.

F. Giorgino, L. Laviola, A. Leonardini, 2005, Diabetes research and clinical practice.

Insulin signaling in human visceral and subcutaneous adipose tissue in vivo.

R. Giorgino, M. De Fazio, F. Giorgino, 2006, Diabetes.

Involvement of the p66Shc protein in glucose transport regulation in skeletal muscle myoblasts.

M. Melchiorre, F. Giorgino, S. Perrini, 2009, American journal of physiology. Endocrinology and metabolism.

Diabetic foot: clinical approach

B. Moretti, A. Leonardini, G. Vicenti, 2022, Minerva Orthopedics.

Exendin-4 Prevents c-Jun N-Terminal Protein Kinase Activation by Tumor Necrosis Factor- (cid:1) (TNF (cid:1) ) and Inhibits TNF (cid:1) -Induced Apoptosis in Insulin-Secreting Cells

P. Marchetti, M. Melchiorre, F. Giorgino, 2010 .

The p66 Shc protein controls redox signaling and oxidation-dependent DNA damage in human liver cells

F. Puglisi, S. Perrini, A. Cignarelli, 2015 .

The Role of Oxidative Stress in Cardiac Disease: From Physiological Response to Injury Factor

F. Giorgino, S. Perrini, A. Cignarelli, 2020, Oxidative medicine and cellular longevity.

Exendin-4 prevents c-Jun N-terminal protein kinase activation by tumor necrosis factor-alpha (TNFalpha) and inhibits TNFalpha-induced apoptosis in insulin-secreting cells.

P. Marchetti, M. Melchiorre, F. Giorgino, 2010, Endocrinology.

Cross-Talk between PPARγ and Insulin Signaling and Modulation of Insulin Sensitivity

F. Giorgino, S. Perrini, A. Natalicchio, 2010, PPAR research.

Abnormalities of the cardiac stem and progenitor cell compartment in experimental and human diabetes

A. Avogaro, A. Leonardini, 2013, Archives of physiology and biochemistry.

Exendin-4 protects pancreatic beta cells from palmitate-induced apoptosis by interfering with GPR40 and the MKK4/7 stress kinase signalling pathway

P. Marchetti, F. Giorgino, S. Perrini, 2013, Diabetologia.

TNFα Signals via p66Shc to Induce E-Selectin, Promote Leukocyte Transmigration and Enhance Permeability in Human Endothelial Cells

M. Melchiorre, F. Giorgino, S. Perrini, 2013, PloS one.

Annals of the New York Academy of Sciences Cardiovascular Disease and Glycemic Control in Type 2 Diabetes: Now That the Dust Is Settling from Large Clinical Trials

F. Giorgino, L. Laviola, A. Leonardini, 2022 .

Multifactorial intervention in Type 2 diabetes: The promise of incretin-based therapies

F. Giorgino, A. Natalicchio, L. Laviola, 2011 .

Biological specificity of visceral adipose tissue and therapeutic intervention

F. Giorgino, S. Perrini, L. Laviola, 2008 .

Multifactorial intervention in Type 2 diabetes: the promise of incretin-based therapies.

F. Giorgino, A. Natalicchio, L. Laviola, 2011, Journal of endocrinological investigation.

1223-P: Effects of Bariatric Surgery on Quality of Life, Body Image, and Sex Life in Obese Women

A. Bertolino, F. Giorgino, S. Perrini, 2021, Diabetes.

Exploiting the pleiotropic actions of GLP-1 for the management of type 2 diabetes mellitus and its complications

F. Giorgino, A. Natalicchio, L. Laviola, 2007 .

Reduction of hypoglycaemia, lifestyle modifications and psychological distress during lockdown following SARS‐CoV‐2 outbreak in type 1 diabetes

F. Giorgino, S. Perrini, A. Cignarelli, 2020 .

Biological specificity of visceral adipose tissue and therapeutic intervention.

F. Giorgino, L. Laviola, A. Leonardini, 2008, Archives of Physiology and Biochemistry.

Erratum to: The p66Shc redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells

M. Bugliani, P. Marchetti, A. Avogaro, 2015, Diabetologia.